Literature DB >> 2281805

Psychopathological and social status of patients with affective, schizophrenic and schizoaffective disorders after long-term course.

A Marneros1, A Deister, A Rohde.   

Abstract

A total of 106 affective, 101 schizoaffective and 148 schizophrenic disorders were investigated after a long-term course of illness (mean follow-up period 25.1 years), employing narrow definitions and using reliable international instruments of evaluation. In addition, the social consequences of the illness were evaluated (upward and downward social and occupational drift, premature retirement and achievement of the expected social development). Considering all aspects of outcome, schizophrenic patients (narrow defined, slightly modified DSM-III criteria) had persistent alterations in several aspects of social life, communication and cognitive functions, in some cases to a very high degree. Although the outcome of affective disorders is not always favourable, it is significantly more favourable than that of schizophrenia. Schizoaffective disorders occupy a position between affective and schizophrenic disorders regarding outcome, but with more similarities to that of affective than to that of schizophrenic disorders.

Entities:  

Mesh:

Year:  1990        PMID: 2281805     DOI: 10.1111/j.1600-0447.1990.tb01400.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  13 in total

1.  Predictors of clinical and social outcomes after hospitalization in schizophrenia.

Authors:  P R Menezes; L C Rodrigues; A H Mann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  Relationship between diagnosis and disposition of patients admitted to a state psychiatric hospital.

Authors:  Claire Advokat; Nancy Eustis; John Pickering
Journal:  Psychiatr Q       Date:  2005

3.  The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity.

Authors:  Hans-Jürgen Möller; Markus Jäger; Michael Riedel; Michael Obermeier; Anton Strauss; Ronald Bottlender
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-05-22       Impact factor: 5.270

4.  Social functioning and age across affective and nonaffective psychoses.

Authors:  Elizabeth A Martin; Dost Öngür; Bruce M Cohen; Kathryn E Lewandowski
Journal:  J Nerv Ment Dis       Date:  2015-01       Impact factor: 2.254

5.  Schizoaffective disorders with and without onset in the puerperium.

Authors:  A Rohde; A Marneros
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

Review 6.  A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder.

Authors:  Pierre Chue; James Chue
Journal:  Ther Clin Risk Manag       Date:  2016-01-27       Impact factor: 2.423

7.  Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder.

Authors:  B L Amann; E J Canales-Rodríguez; M Madre; J Radua; G Monte; S Alonso-Lana; R Landin-Romero; A Moreno-Alcázar; C M Bonnin; S Sarró; J Ortiz-Gil; J J Gomar; N Moro; P Fernandez-Corcuera; J M Goikolea; J Blanch; R Salvador; E Vieta; P J McKenna; E Pomarol-Clotet
Journal:  Acta Psychiatr Scand       Date:  2015-05-13       Impact factor: 6.392

8.  Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature.

Authors:  Daniel J Abrams; Donald C Rojas; David B Arciniegas
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

9.  Social class, social mobility and risk of psychiatric disorder--a population-based longitudinal study.

Authors:  Sanna Tiikkaja; Sven Sandin; Ninoa Malki; Bitte Modin; Pär Sparén; Christina M Hultman
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

Review 10.  Considerations on assisted resilience and individualized therapy in bipolar affective disorder, with a clinical case exemplification.

Authors:  Alexandra Bolos
Journal:  Clujul Med       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.